JOURNAL BACTERIOLOGY, Mar. 1992, p. 1750-1759                                                                   Vol. 174,  6
0021-9193/92/061750-10$02.00/0
Copyright X) 1992, American Society Microbiology


    Replacement folC Gene, Encoding Folylpolyglutamate
Synthetase-Dihydrofolate Synthetase Escherichia coli, Genes
                       Mutagenized Vitro
                                          CARON PYNE ANDREW L. BOGNAR*
                      Department Microbiology, University Toronto, Toronto, Ontario, Canada MSS 1A8
                                           Received 26 July 1991/Accepted 13 January 1992

              folylpolyglutamate synthetase-dihydrofolate synthetase gene (foiC) Escherichia coli deleted            bacterial chromosome replaced selectable Kmr marker. deletion strain required            complementing gene expressing folylpolyglutamate synthetase encoded plasmid viability, indicating
           thatfoiC essential gene E. coli. complementingfoiC gene cloned vector pPM103
           (pSC101, temperature sensitive replication), segregated spontaneously 42°C absence            selection. complementing plasmid replaced thefoiC deletion strain compatible pUC plasmids
           containing foiC genes mutations generated vitro, producing strains express mutant
           folylpolyglutamate synthetase. MutantfolC genes expressing insufficient enzyme activity complement
           chromosomal deletion, resulting retention pPM103 plasmid. mutant genes expressing low
           levels enzyme activity replaced complementing plasmid, strains produced auxotrophic            products folate-dependent pathways. folylpolyglutamate synthetase gene Lactobacilus casei,            lack dihydrofolate synthetase activity, replaced complementing plasmid, strain            auxotrophic folate end products.

  Escherichia coli foiC gene product, folylpolygluta-           recent report deletion folA gene encoding
mate synthetase (FPGS)-dihydrofolate synthetase,           dihydrofolate reductase poLA thyA strain integration
zyme catalyzing distinct reactions folate biosyn-        recombinant plasmids containing ColEl origin thetic pathway. dihydrofolate synthetase activity adds          subsequent segregation (14) suggested 
L-glutamate dihydropteroate form dihydrofolate. Dihy-         structing deletion foiC similar method drofolate reduced tetrahydrofolate cell dihy-       successful.
drofolate reductase. FPGS activity foiC product             SF4 mutant strain contains folC gene point adds second glutamate y-linkage              mutation causing alani, e threonine amino acid change
tetrahydrofolates form polyglutamates. second enzyme           codon 309 (16) ,dires methionine growth (11).
catalyzes addition glutamates link-        Plasmid-encoded mutant foiC genes express little
age triglutamate (10, 12).                                   1  wild-type activity FPGS dihydro-
  Ferone et al. reported isolation foiC mutant             folate synthetase complemented SF4 methionine prototro-
(W1485 21 [11] SF2 SF4 [5]) auxotrophic               phy (16, 17). Lactobacillus casei FPGS gene, methionine stimulated glycine absence              little dihydrofolate synthetase activity, com-
vitamin B12. mutant leaky cells            plement SF4 (31). constructed number folC
dihydrofolate synthetase FPGS activity levels 1 3         mutants multicopy plasmids vitro mutagenesis, levels wild-type strain possess 10 30       study properties hampered 
normal total folate pools (11). dihydrofolate           ground enzyme activity SF4 strain. report, synthetase activity required folate biosynthesis,          demonstrate deletion chromosomal folC gene nonleaky mutant having residual enzyme activity            presence complementing gene plasmid temper- folates. mutant require folate      ature sensitive replication. complementing plasmid
end products (thymine, purines, glycine, methionine,            replaced second plasmid containing foiC
pantothenate), lethal, folate            mutant gene, provided gene product expresses
required synthesis formyl methionine initiation       sufficient enzyme activity. allows  study protein synthesis. wished obtain afolC mutant           folC mutants synthesized vitro absence 
completely lacks FPGS-dihydrofolate synthetase activity          ground FPGS-dihydrofolate synthetase activity encoded investigate phenotype.                                          chromosome.
  number methods gene disruption allele
replacement E. coli reported previously (3, 14,
15, 33). Double-stranded linear DNA fragments containing                             MATERIALS METHODS folC gene Kmr cassette inserted coding
sequence failed transform recBC sbcB strain kana-                 Materials.  32P]dATP (7,000 Ci/mmol),  32P]dCTP
mycin resistance. hands methods did work               (7,000 Ci/mmol), para-amino[carboxyl-14C]benzoic acid (54 presence complementing wild-type plasmid.              mCi/mmol), L-[U-14C]glutamic acid (10 mCi/mmol)                                                                         obtained Amersham Corp. Tran35S-label (methionine)
                                                                        obtained ICN Pharmaceuticals. Fluorography 
                                                                        agents (i3n3Hance), Aquasol, nylon membranes   *
      Corresponding   author.                                           New England Nuclear. Nitrocellulose obtained
                                                                 1750
 VOL. 174, 1992                                    REPLACEMENT foiC VITRO-MUTAGENIZED GENES                         1751

                                              TABLE 1. Plasmids used study
             Plasmid(s)                                                   Description                                  Reference(s)
pUC19                                    Cloning vector; Ampr                                                          24
pH2A-1                                   pKC7 usg, folC, dedD genes 10-kb fragment; Ampr Kmr             5
pCP1                                     pH2A-1 deletion 1-kb SphI fragment inactivating Km' gene; Ampr        study
pCP2                                     pCP1 deletion folC dedD; Ampr                                     study
pCP3                                     pCP2 Kmr gene fromn pUC4K StuI site; Ampr Kmr                     study
pAC3                                     pUC8 3.5-kb fragment containing usg, foiC, dedD genes; Ampr          4
pPM103                                   pSC101 temperature sensitive replication; segregates 30°C; Tetr     15, 20
pPMpac3                                  pPM103 containing 3.5-kb insert pAC3; Tetr                               study
pPMusg                                   pPMpac3 deletion dedD foiC; Tet'                                  study
pPMdedD                                  pPMpac3 deletion usg foiC; Tetr                                   study
pAC5                                     pUC9 folC gene downstream lac promoter; Ampr                          4
pAC6                                     pUC19 PvuII fragment containing folC gene pAC5; Ampr                study
pPMfolC/amp                              pPM103 containing pAC6 EcoRI site; Ampr Tetr                           study
pPMfolC                                  pPM103 folC gene downstream lac promoter; Tetr                        study
pUGBgl                                   pUC19 usg linker correct 3' end usg; Ampr                      6
pUC4K                                    pUC4 containing Kmr cassette; Ampr                                       Pharmacia
pGly, pIleu, pArg, pGlu, pVAl, pLeu      pUC19 dedD gene foiC gene codon 309 mutation               16
                                           indicated amino acid; Amnpr
pSF4                                     pUC19 foIC dedD genes cloned SF4 mutant strain; Ampr            16
pGT3-8.1                                 pEMBL18+ L. casei FPGS gene; Ampr                                        31
pL2, pL4, pL5, pL6, pL8, pLlO            pAC5 6-bp linker inserted various sites; Ampr                         17


 Schleicher & Schuell. Tetrahydrofolate, folinic acid,          DNA isolated E. coli strains method adenosine, thymidine, ATP, methionine, glycine, glutamic            Driver Lawther (8) DNA spooled
acid, antibiotics kanamycin, tetracycline, chlor-       glass rod overlay 2 volumes ice-cold
amphenicol purchased Sigma Chemical                    ethanol phenol-chloroform extraction DNA
Ampicillin proteinase K Boehringer Mann-              redissolved TE buffer overnight gentle agitation
heim. Geneclean kit purchased Bio 101.                 prior digestion restriction endonuclease. Southern
Restriction endonucleases, RNases, DNA modifying                blots performed following transfer DNA nitrocel-
enzymes purchased Boehringer Mannheim, Phar-              lulose nylon membranes hybridizations described
macia, Bethesda Research Laboratories.                           Southern (28) appropriate probes 42°C 50 
  Bacterial strains, phage, plasmids, media. Strain             formamide. DNA probes labelled [ac-32P]dCTP MM383 [thyA polA12(Ts) Rha- Lac- Strrl (22) gen-              random prinier procedure Feinberg Vogelstein (9)
erous gift J. Brunton, Mount Sinai Research Institute,           using Klenow fragment DNA polymerase  Transfor-
Toronto, Canada. SF2 (foiC strA) previously                mation method Hanahan (13), described (5). SF4 (folC strA recA srlC::TnlO) (5) used         temperature-sensitive MM383 cells strains recipient strain verify insertion foiC gene     transformed pPM103-derived plasmids, plasmid constructions. JF1754 (hsdR lac gal metB leuB          instance cells grown 30°C heat shock step
hisB) (19) used highly competent host plasmid           37°C. Selection integrants YT
constructions. DR1984 (25) host strain used             plates supplemented 25 p,g ampicillin ml  maxicell studies. Phage P1 (cml clrlOO) (21) gift M.       cells grown 37°C) followed streaking YT
Herrington, Concordia University, Montreal, Canada.             plates containing 25 ,ug kanamycin ml. plasmids used study listed Table 1. Plasmid          pPM103 plasmid reported temperature sensitive
pPM103 gift M. Toth, M T.                                replication (15, 20), transformants grew   E. coli strains grown 2YT LB (21) medium
supplemented ampicillin (50 ,ug/ml), kanamycin (50             presence tetracycline 42°C. plasmid segregated
,ug/ml), tet-racycline (10 ,ug/ml), chloramphenicol (12.5        high frequency,  grown absence ,ug/ml) indicated. SF4 grown Vogel-Bonner              selection 37°C higher  low frequency minimal medium (32) supplemented methionine (50                30°C). order maintain complementing pPM103-
jig/ml) glycine (50 ,ug/ml). Unsupplemented minimal             derived plasmids appropriate E. coli strains, cells
medium solidified 1.5  agar used complemen-             grown presence tetracycline 30°C.
tation analysis. Strain MM383 grown 2YT medium                  Transduction foiC deletion Pol+ strains. supplemented thymidine (200 ,g/ml). following              MM383AfolC/pPMpac3a strain lysogenized P1 (cml
folate end products added minimal medium                clrlOO), lysates prepared standard methods (21).
growth SF2AfolC strain transformed mutant               Cells E. coli SF2 JF1754 containing plasmid
derivatives folC gene: methionine, 50 ,ug/ml; glycine,       pPMpac3a infected lysate, plated kanamy-
50 ,ug/ml; adenosine, 20 ,ug/ml; thymidine, 200 ,ug/ml; pan-        cin resistance-selective plates, incubated 30°C.
tothenate, 1 ,ug/ml; serine, 50 ,ug/ml.                            Enzyme extraction assay. Cells grown 1-liter
   Plasmid isolation, DNA modification analysis,            cultures YT medium supplemented 100 ,ug ampi-
bacterial transformation. Plasmid preparations         cillin ml. Cells harvested centrifugation alkaline lysis procedure (2). Restriction endonuclease          lysed sonication Branson sonifier. Solid ammonium
digestions, nuclease digestions, ligations carried         sulfate added 60  (wt/vol) cleared lysate (50 according manufacturer's instructions. Genomic           ml), precipitate collected centrifugation.  1752     PYNE BOGNAR                                                                                         J. BACTERIOL.

fraction resuspended 5 10 ml 50 mM Tris HCI,         ampicillin selection, AmpS KmS segregants,
pH 7.5.                                                           verified wild type Southern blots     FPGS activity measured incorporation             shown), Amp' Km' segregants, ['4C]glutamate (1 mM) folate products described           possess deletions folC dedD genes, obtained.
previously (7, 27). 5,10-methylenetetrahydrofolate (100         results described suggested foIC ,uM) 10-formyltetrahydrofolate (100 ,uM) used         essential gene viable MM383 derivatives folate substrates. Dihydrofolate synthetase activity          deletion chromosomal folC gene measured dihydropteroate (25 ,uM) substrate          require complementing gene plasmid previously described (5).                                         replicate polA strain. examine genes
   Incorporation labelled para-aminobenzoic acid cellu-   affected deletion, constructed
lar folates. 2YT medium pretreated activated             recombinant plasmids containing folC gene (pPMfolC)
charcoal filtered remove folates para-ami-          expressed lac promoter, upstream gene
nobenzoic acid. para-Amino[carboxyl-'4C]benzoic acid (54          (pPMusg), dedD gene (pPMdedD), genes
mCi/mmol) added 20 ml medium (12,000                (pPMpac3a) DNA fragments inserted pPM103
cpm/ml) concentration 0.2 FtM. medium             vector replicate MM383 poL4 strain (Fig. 4
inoculated appropriate E. coli strains shaken    5). structures plasmids verified 24 h. cells washed twice centrifugation           restriction endonuclease analysis, plasmid-depen-
counted using Aquasol scintillation fluid.                     dent expression appropriate gene products veri-
  Analysis plasmid-encoded gene products maxicells. E.      fied maxicell experiments (data shown). Expression
coli DR1984 transformed various plasmids             folC pPMpac3a pPMfolC verified irradiated UV light, plasmid-encoded proteins       complementation strain SF4 methionine prototrophy.
labelled Tran3 S-label (methionine cysteine)             Strain MM383::pCP3 transformed tetracycline 
described Sancar et al. (26). Sodium dodecyl sulfate-          sistance plasmids described  Tetr
polyacrylamide gel electrophoresis performed 13          transformants grown absence ampicillin polyacrylamide gels according method Laemmli            screen segregants integrated pCP3 plasmid. Wild-
(18), gels fluorographed.                            type segregants obtained transformants,                                                                   Amp' Kmr segregants obtained transfor-
                          RESULTS                                 mants containing pPMfolC pPMpac3a plasmids.
                                                                  strains designated MM383AfolC/pPMfolC    Construction plasmid pCP3. construction pCP3      MM383AfolC/pPMpac3a, respectively. Amp' Kmr seg-
shown Fig. 1. plasmid constructs verified          regants observed strains transformed restriction enzyme analysis, including redigestion pCP3        pPMusg pPMdedD, cells grown StuI (data shown).                                       selected rich medium supplemented folate end
   gene products expressed pCP3 analyzed         products methionine, glycine, thymidine, adenosine, maxicells (Fig. 2, lane 3). pCP3 plasmid expressed        pantothenate. Amp' Kmr segregants containing
labelled protein products expressed parent plasmid         pPMfolC grew normally, dedD gene H2al (lane 4) did express products foiC        deleted present complementing plasmid. gene, dedD gene, TnS Kmr gene (kan 2 Fig. 2),       difference phenotype observed result genes deleted construction pCP3.       deletion dedD gene.
ThefolC product (molecular mass, 47 kDa) shown lanes           deletion chromosomal foiC gene strain
2, 4, 5. dedD product (35 kDa) shown lane 4     MM383AfolC/pPMpac3 verified Southern blotting. present faint band lane 2. product     Figure 3B, lane 7, shows MM383::pCP3 integrant 1 contain-
Kmr gene pUC4K (lane 1) appears             ing plasmid pPMpac3a. plasmid-specific bands hybrid-
mobility ,-lactamase visible discrete      izing probe shown lane 9. Lane 8 shows band.                                                             corresponding segregant, MM383AfolC/pPMpac3a,    Integration pCP3 deletion chromosomal se-            pPMpac3a-specific bands seen 5-kb
quences. strategy disruption chromosomal           fragments integrant absent. present lane 8
folC gene shown Fig. 3A. pCP3 contains selectable         8.3- 2.7-kb fragments expected segregant Kmr marker replacing deletedfolC dedD genes,          chromosomal region containing foiC dedD marker flanked extensive E. coli genomic DNA            genes replaced Kmr marker (Fig. 3A, left).
sequences required homologous recombination. pCP3                Replacement thefoiC gene vitro-generated mutant used transform polA(Ts) strain MM383 ampi-          genes. objectives deleting folC gene cillin kanamycin resistance. tried times       express mutantfolC genes produced vitro mutagenesis unable isolate plasmid transformants          strain chromosomally encoded background
MM383, suggesting plasmids directly inte-        enzyme activity. mutants constructed
grated chromosome. Integration intact pCP3       ColEl replicons, necessary transduce chro- chromosomes Ampr Kmr transformants verified            mosomal foiC deletion PolA+ strain using bacte- Southern blot analysis (Fig. 3B). pCP3 probe hybrid-       riophage P1 described Materials Methods. ized 9-kb 2.7-kb EcoRI fragment host strain     selected Kmr transductants strain SF2 containing
(lanes 1 2). recombination event occur           pPMpac3a plasmid. obtained Kmr transductants deletion (Fig. 3A), possible          recipient strain did contain complementing
integrants obtained. Fig. 3B, lane 3, shows integrant 2,     pPMpac3a plasmid. loss chromosomal foiC gene hybridizing fragments 2.7, 5, 5.7, 8.3 kb.   strains verified Southern blot analysis. Integrant 1 shown lanes 4 6 hybridizing             blot shown Fig. 3C BamHI-HindIII fragment fragments 2.7 9 kb 5 kb. Following growth       plasmid pACS (Fig. 5) used afolC-specific probe. Lanes integrants, designated MM383::pCP3, absence         1 2 strain SF2AfolC/pPMpac3a. probe hybrid-
 VOL. 174, 1992                                          REPLACEMENT folC VITRO-MUTAGENIZED GENES                                1753



                                              foIC dedD
                                 usg                        Stul
                              EcoRi


                           EcoRI
                           EcoRI                     pH2al
                             Hindlil


                                        Sphi                        EcoRil                         pUC4K
                                   Sphl digestion
                                          Ligation                                         BamHI                BamHI
                                                     pCP1                                              KAN
                                 Stul digestion
                                       Ugation

                                         usg                         Stul                                                                                                              911
                                            /EcoRI \                                 EcoRI         /

                                                                                     usg
                           EcoR                pCP2                                                  pUGBgl



                                       indill                        ind >l

                                                        Stul digestion                  Stul digestion

                                                            AGGCCTGAGATCC           Ligation


                                                              ECOfi S u/                   Stul
                                                                     gusg


                                                      EcoRI                  pCP3
                                                      EcoRI
                                                      Hindlill
                                                          Sphl
                                                                            c o
                                                                                      indlill
                                                                                   R 1~EoR
   FIG. 1. Construction pCP3. Plasmid pH2A-1 (5) digested SphI religated form pCP1. procedure removed 1-kb
fragment pKC7 vector portion plasmid inactivated kanamycin resistance gene. pCP1 digested StuI religated form pCP2. procedure removed 2-kb DNA fragment containing folC gene adjacent downstream gene (dedD)
(23). deletion removed 5 bases, including termination codon usg. Km' cassette inserted pCP2 constructed follows: plasmid pUC4K (Pharmacia) digested BamHI, 1.3-kb DNA fragment containing kanamycin
phosphotransferase gene isolated agarose gel ligated BglII site pUGBgl (6). pUGBgl linker consisting BglII site flanked StuI sites, contains DNA sequences provide proper termination upstream gene allowing
insertions BglII site (6). kanamycin resistance cassette cloned BglII site pUGBgl excised StuI digestion flanked linker sequences. DNA fragment gel purified ligated StuI site pCP2 form pCP3. pCP3 transformed competent E. coli cells, Kmr Ampr colonies selected. DNA sequences follows:             , vector; _, E. coli;
EL1, open reading frames specific genes. DNA sequence StuI BglII-BamHI sites adjacent usg shown. TGA
stop codon frame usg provide correct translation termination highlighted.
 1754            PYNE BOGNAR                                                                                              J. BACTERIOL.

                  1   2     3      4      5                             transformants grown 37°C absence tetracy-
                                                                        cline replica plated tetracycline-supplemented
       93-                                                              medium screen segregation pPMpac3a plasmid.
       68..                                                             colonies pAC5-transformed cells                                                  4 pur F                tetracycline sensitive, indicating pPMpac3a plasmid
       43-                                       -4folC                 segregated, pUC19-transformed cells
                                                 w hisT-usg             tetracycline sensitive. pPMpac3a plasmid segre-
       30._                                      .-ded D                gated transformants containing codon 309 point
                                                  wusg                  mutants plated complex medium.                                                   * aamp  kan 1         SF2AfolC strains containing pVal, pArg, pLeu, pGlu
                                                     kan h
       21   -                                                           grew slowly wild type. SF2AfolC strains
                                                                        transformed linker insertion mutants         14                                                               <5  wild-type FPGS dihydrofolate synthetase
                                                                        activity) (17) unable segregate pPMpac3a plas-
   FIG. 2. Expression plasmid-dependent proteins maxicells.       mid grown complex medium.
DR1984 cells transformed pUC4K (lane 1), pAC3 (lane 2),          experiment, pPMpac3a plasmid segregated
pCP3 (lane 3), pH2al (lane 4), pAC5 (lane 5). plasmids      SF2AfolC/pGT3-8.1, (containing L. casei FPGS
described Table 1. Sodium dodecyl sulfate-polyacrylamide gels     gene). SF2AfolC/pGT3-8.1 grew complex medium
total cell extracts autoradiographed detect proteins labelled   stably maintained, able Tran35S-label (methionine cysteine). positions molecular weight markers indicated left. positions    repeat transformation segregation experiment identified gene products shown right. kan 1, kanamycin       produced strain. loss chromosomal resistance gene pUC4K derived Tn9O3; kan 2, kanamycin         pPMpac3a-encoded folC genes Tets strains resistance gene, derived TnS, present pH2al; hisT-usg,          pPMpac3a segregated verified Southern
product gene upstream hisT (23). sample lane 5       blotting. Figure 3B, lanes 4 6, shows thefolC-specific separate experiment higher background labelled         probe hybridized 4- 4.7-kb DNA fragments spe-
cellular proteins.                                                      cific replacing plasmids 2.6-kb
                                                                        pPMpac3a plasmid-specific fragment (lane 2) chromo-
                                                                        somal integrant. Lane 4 contained DNA
ized 4.5-kb EcoRI 2.7-kb EcoRI-Smal                 lanes 5 6 did, L. casei FPGS gene-specific
fragments corresponding pPMpac3a-encoded folC                    DNA hybridized weakly folC probe. verify
gene 9-kb chromosomal EcoRI fragment                SF2AfolC/pGT3-8.1 contained L. casei FPGS parental strain, SF2 (shown lane 3). SmaI           gene, extracts strain controls assayed sites chromosomal EcoRI fragment (23).                      FPGS dihydrofolate synthetase activity. Table 2 shows
   SF2AfolC/pPMpac3a transformed ampicillin resis-               SF2AfolC/pGT8-1 high expression FPGS
tance plasmids pUC19 pAC5 (wild-type folC gene                 activity,withsixfold-higheractivitywith5,10-methylenetetra- pUC19) plasmids containing mutatedfolC genes pUC               hydrofolate 10-formyl tetrahydrofolate, similar vectors (Table 1). pL2, pIA, pL5, pL6, pL8, pLlO               specificity enzyme purified L. casei. derived pAC5 contain 2-amino-acid linker inser-                dihydrofolate synthetase specific activity tions various points foiC coding sequence (17).               wild-type E. coli, indicating chromosomal Plasmids pSF4, pGly, pIleu, pVal, pArg, pGlu, pLeu                  pPMpac3a foiC genes absent. apparent dihydrofo-
contain point mutations codon 309 foiC  site           late synthetase activity L. casei FPGS mutation SF4), DNA inserts contain                  traces folate pteroate substrate. Table 3
entire dedD gene (16). Plasmid pGT3-8.1 contains L.                 shows incorporation 14C-para-aminobenzoic acid casei FPGS gene (30). mutant plasmids tested,                cells, measure folate biosynthesis pArg, pLeu, pGlu, transformed strain SF4                  dihydrofolate synthetase activity. incorporation label
methionine prototrophy. SF2AfolC/pPMpac3a Ampr                      SF2AfolC/pGT3-8.1 50-fold lower 

   FIG. 3. Integration pCP3 segregation E. coli chromosome.   pCP3 plasmid EcoRI restriction map E. coli chromosomal DNA vicinity foiC gene. region containing foiC dedD genes deleted E. coli DNA pCP3 boxed. recombination events (1 2) gave rise integrants shown. Immediately plasmid EcoRI restriction maps E. coli chromosomal DNA integrants 1 2. lowermost level shows maps following
segregation plasmid: map left shows chromosomal DNA foiC gene deleted replaced Kmr marker; map right shows wild-type segregant (WT). ThefoiC, dedD, Kmr, Ampr genes boxed. sizes restriction fragments hybridized probe linearized radiolabelled pCP3 plasmid indicated restriction maps host strain; integrants thefolC-deleted segregant indicated divergent arrowheads. restriction fragment hybridized thefolC-specific
gene probe  BamHI-HindIII fragment pAC5, shown Fig. 5) indicated restriction map wild-type segregant. (B)
Southern hybridizations wild-type, integrant, segregant genomic DNA. Chromosomal DNA digested EcoRI probed pCP3 plasmid DNA. Lanes 1 2, MM383; lane 3, MM383::pCP3 integrant 2; lanes 4 6, MM383::pCP3 integrant 1; lane 7,
MM383::pCP3/pPMpac3a  lane 6 containing plasmid pPMpac3a); lane 8, MM383AfolC/pPMpac3a; lane 9, pPMpac3a plasmid
DNA  Fig. 4 restriction map). arrowhead indicates position 8.3-kbp band lane 8 present chromosomal folC deleted. (C) Southern hybridizations wild-type folC-deleted strains containing complementing plasmids.
Chromosomal DNA digested EcoRI (lane 1) EcoRI SmaI (lanes 2 6) probed polyacrylamide gel-purified radiolabelled pAC5 insert DNA (Fig. 5), specific thefolC coding sequence. Lanes 1 2, SF2AfolC/pPMpac3a; lane 3, SF2; lane
4, SF2AfolC/pGT3-8.1; lane 5, SF2AfolC/pSF4; lane 6, SF2AfolC/pAC5. pPMpac3a described Fig. 4 legend. additional bands
corresponding wild-type genomic fragment integrated plasmids observed sixfold longer exposure autoradiogram.
 VOL. 174, 1992                                                  REPLACEMENT folC VITRO-MUTAGENIZED GENES                                      1755




                                                           -2.7 kbE     -
                                                                                        9 kb


                                     



                  EE       E
                                   5.0 kb 5.0 kb
                                         E
                                                 1

                                                     EE   -EK
                                                                  9kb
                                                                            E
                                                                                             E E
                                                                                                     5.7kb

                                                                                                             E
                                                                                                                  5.0kb
                                                                                                                       2

                                                                                                                            EE   E
                                                                                                                                         8.3kb

                                                                                                                                                 E
                  II -S     a_                         -t                                     111A
                                                                                                   kIJ




                       E
                       II
                                    2.7kb
                                             E
                                                          8.3kb
                                                                                E
                                                                                             E E
                                                                                               1
                                                                                                             E
                                                                                                                                                                                                                                                                  E



                                                                                                                 -qc             9.0kb

                                                 FOL                                                                 WT

                           B l                                                             cl 2              3             456
                 23 kb.
                  9.4-_1
                  6.5 _.
                                                                                                                                            _23kb
                                                                                                                                            - 9.4
                  4.3                                                                                                                       - 6.5

                                                                                                                                            - 4.0

                  2.3          -



                                                                                                                                            -    2.3
                                                                                                                                            -    2.0
 1756     PYNE BOGNAR                                                                                                       J. BACTrERIOL.




                                                                                            Xhol
                                                                                            paral Sail
                                                                                            religate




  FIG. 4. Construction plasmids pPM103. Plasmid pAC3 digested SmaI HindIII. cohesive ends produced HindIII filled Klenow fragment DNA polymerase  DNA ligated pPM103 digested SmaI dephosphorylated calf intestine alkaline phosphatase. ligated plasmids used transform E. coli JF1754 selecting tetracycline resistance ampicillin sensitivity. resultant plasmid, designated pPMpac3, obtained possible orientations, pPMpac3a pPMpac3b. construct pPMusg, pPMpac3a digested XhoI partially Sall religated. Transformants retained tetracycline
resistance, indicating SalI site tet gene intact, selected. digestion removes dedD gene half folC
gene. religated plasmid pPMusg retained upstream gene promoter. construct pPMdedD, pPMpac3b digested XhoI partially Sall religated. upstream gene half folC gene deleted. religated plasmid pPMdedD
contained dedD gene promoter, located 3' half foiC gene. DNA sequences follows:           , vector; LII, open
reading frames E. coli genes; '-, antibiotic resistance genes.


SF4 mutant strain 500-fold lower wild-type            grown minimal medium, liquid solidified,
E. coli. results consistent absence                containing various nutritional supplements folate end
dihydrofolate synthetase activity SF2AfoiC strain             products. SF2AfoiC strains containing plasmids pAC5 (wild- dihydrofolate synthetase activity L. casei FPGS            typefolC), pGly, pSF4, plleu, pVal able grow gene product 0.2 12  present              minimal medium, growth rates wild-type E. coli cells.                                                 lower (16). SF2AfoiC/pArg produced microcolonies   SF2AfolC strains containing mutant folC genes                 solidified minimal medium required methionine complementing pPM103 plasmid segregated                    glycine growth liquid medium. SF2AfoIC/pGlu
 VOL. 174, 1992                                       REPLACEMENT folC VITRO-MUTAGENIZED GENES                              1757




  FIG. 5. Construction pPMfolC. Plasmid pAC5 digested PvuII, fragment containing folC gene downstream lac promoter isolated agarose gel ligated pUC19 digested Sma  plasmids isolated Ampr transformants, orientation insert excised EcoRI fragment selected. plasmid, pAC6, digested EcoRI ligated pPM103 linearized EcoRI. Tetr transformants E. coli JF1754 selected pooled, plasmid
DNA isolated. plasmids pool used transform E. coli SF2 methionine prototrophy, selecting plasmids
containing functional folC gene. Tetr colonies obtained Ampr. Restriction analysis plasmids isolated transformants showed hybrid plasmid, pPMfolC/amp, caused ligation linearized plasmids EcoRI
digest pAC6 partial digest. pPMfolC/amp digested PvuI religated delete Ampr gene. resultant plasmid,
pPMfolC, replicate MM383 poL4 strain E. coli complement folC mutation strain SF4. Transformants pPMfolC Tetr AmpS. DNA sequences follows:            , pPM103; _, pUC19; El, open reading frames E. coli genes; ',
antibiotic resistance genes. Open arrowheads indicate lac promoter.

strain required supplements methionine, glycine, thy-             gene viable unless deleted gene comple-
midine, adenosine growth. SF2AfolC/pLeu                    mented functional plasmid-encoded gene. Transduc-
strain SF2AfolC/pGT3-8.1 strain required            tion chromosomal deletion using Kmr marker
folate end products (including pantothenate) growth.               required presence complementing gene                                                                        recipient strain. presence thyA mutation E. coli
                         DISCUSSION                                    allows deletion thefoLA gene encoding dihydrofolate
                                                                       reductase (14), deletion offolC lethal thyA
   results indicate thefoiC gene essential gene         strain. sufficient include end products E. coli. Segregants deleted chromosomal folC              folate-dependent biosynthetic pathways medium  1758        PYNE BOGNAR                                                                                                                J. BACTIEkRIOL.

       TABLE 2. FPGS dihydrofolate synthetase E. coli                         biosynthesis, biosynthesis nucleotides pantoth-
                  strains transformantsa                                         enate sensitive. Studies measure levels                                                 Relative sp act'                     folate strains described progress  Strain/transformant                                                                 allow determine folate concentrations limit
                              H2Pte      5,10-CH2-H4Pteglu     10-CHO-H4Pteglu       growth cell functioning folate-
W1485C                         1                   1                     1           dependent biosynthetic pathway.
SF2AfolC/pPMpac3               1.3                 1.1                   5.3            strain containing L. casei gene, SF2AfolC/pGT3-
SF2AfolC/pAC5                180                 134                   139           8.1, expresses levels FPGS activity 1.8-fold
SF2AfolC/pGT3-8.1              0.12            1,438                   248           higher SF2AJolC/pAC5 E. coli foiC
  Experimental details described Materials Methods.                     gene vector.  SF2AfolCIpGT3-8.1   b Abbreviations: H2Pte, dihydropteroate; 5,10-CH2-H4Pteglu, 5,10-methyl-           auxotrophic folate end products. auxotro-
enetetrahydrofolate; 10-CHO-H4Pteglu, 10-formyl-tetrahydrofolate.                    phy probably extremely low levels dihydrofolate
  c Typical specific activities extracts 1, 1.8, 5.9 nmol/h/mg     synthetase activity L. casei enzyme. incorpora- H2Pte, 5,10-CH2H4Pteglu, 10-CHO-H4Pteglu, respectively.                     tion ofpara-aminobenzoic acid, measure folate synthe-
                                                                                     sis, 0.2  wild type SF2AfolC/pGT3-8.1.
                                                                                     dihydrofolate synthetase-specific activity L. casei
complement folC function, FPGS-deficient                             enzyme (Table 2) 1/10,000 E. coli enzyme,
Chinese hamster ovary cells (29). folate requirement                         high expression L. casei gene, total
synthesis formyl-methionyl-tRNA initiation                             enzyme activity sufficient account protein synthesis satisfied supple-                            viability SF2AfolC/pGT3-8.1. Preliminary results ments (11). biosynthesis folate requires dihy-                          extraction high-performance liquid chromatography drofolate synthetase, dihydrofolate synthetase activity                       cellular folates suggest SF2AfolC/pGT3-8.1 does contain folC gene product essential.                                  folates (30), favoring interpretation. L. casei gene obtained folC mutants dihydrofolate syn-                              strain undergone mutation thetase activity FPGS activity,                               dihydrofolate synthetase activity, determine dihydrofolate synthetase activity                         able repeat experiment constructed sufficient cell viability. loss FPGS                            strain. alternate possibility E. coli genome simply result methionine auxotrophy (11).                                         recipient SF2AfolC transformed pGT3-8.1
   major application strains constructed                         undergone second mutation, making able initiate recipient strains mutant foiC genes, synthesized                           protein synthesis formyl methionine. mutant
vitro, allow examination mutants absence                         reported literature (1), background activity chromosomal gene.                               subsequently lost. constructed strains strain FPGS gene L. casei replaced folC gene.                                              ACKNOWLEDGMENTS able purify mutant enzymes study                                   work supported grant MA-9822 Medical
properties. mutant genes present high copy                           Research Council Canada.
number, enzymes expressed 4                                   thank J. B. McNeil S. McCracken reading soluble cellular protein, strains complemented                         manuscript. pGlu, pArg, pLeu mutant genes, enzyme-specific                                                      REFERENCES
activity cells lower wild type
(16). lower specific activity enzyme                           1. Baumstark, B. R., L. L. Spremulli, U. L. R#jBhandary, supplements folate end products required                                G. M. Brown. 1977. Initiation protein synthesis growth. decrease enzyme activity IB1 (SF2                              formylation mutant Escherichia coli grows                                                                                          absence tetrahydrofolate. J. Bacteriol. 129:457-471.
SF4) strain resulted 70  decrease intracellular folate                        2. Birnboim, H. C., J. Doly. 1979. rapid alkaline extraction
pools (11). level enzyme activity lower                               procedure screening recombinant plasmid DNA. Nucleic SF2AfolC/pArg, SF2AfolC/pLeu, SF2AfolC/pGlu                                      Acids Res. 7:1513-1523.
strains SF2, suggesting folate pools                              3. Blum, P., D. Holzschu, H.-S. Kwan, D. Riggs, S. Artz. 1989.
lower strains, resulting lower growth rates                          Gene replacement retrieval recombinant M13mp bac-
auxotrophies. methionine biosynthetic pathway appears                                teriophages. J. Bacteriol. 171:538-546. sensitive low folate, followed glycine                               4. Bognar, , C. Osborne, B. Shane. 1987. Primary structure
                                                                                         Escherichia coli folC gene folylpolyglutamate
                                                                                         synthetase-dihydrofolate synthetase product regulation                                                                                          expression upstream gene. J. Biol. Chem. 262:12337-
  TABLE 3. Incorporation para-amino[carboxyl-'4C]benzoic                              12343.
                  acid E. coli strainsa                                          5. Bognar,  L., C. Osborne, B. Shane, S. Singer, R. Ferone.
                                                                    pmol pABA
                                                                                         1983. Escherichia coli folylpolyglutamate synthetase-dihydrofo-
        Strain                                                     incorporated/mg       late synthetase, gene cloning high expression, purification
                                                                       cellsb         properties. J. Biol. Chem. 260:5625-5630.
                                                                                      6. Bognar,  L., C. Pyne, M. Yu, G. Basi. 1989. Transcription
W1485C .287                                                                              folC gene coding folylpolyglutamate synthetase-
SF4 ........................................                            24               dihydrofolate synthetase Escherichia coli. J. Bacteriol. 171:
SF2AfolC/pGT3-8.1 ........................................               0.53            1854-1861.
  Experimental details described Materials Methods.                      7. Bognar,  L., B. Shane. 1983. Purification properties   b          SF2AfoIC/pGT3-8.1 cells grew 40  density             Lactobacillus casei folylpolyglutamate synthetase. J. Biol.
strains; 1 ml cells optical density  550 nm) 1 assumed          Chem. 258:12574-12581.
1 mg cells. pABA, pam-aminobenzoic acid.                                           8. Driver, R. P., R. P. Lawther. 1985. Physical analysis   c wild-type cells incorporated 68  labelled pABA                 deletion mutants ilvGEDA operon Eschenchia coli
course experiment.                                                                K-12. J. Bacteriol. 162:598-606.
 VOL. 174, 1992                                         REPLACEMENT folC VITRO-MUTAGENIZED GENES                                1759

 9. Feinberg,  P., B. Vogelstein. 1983. technique            21. Miller, J. H. 1972. Experiments molecular genetics, p.
    radiolabelling DNA restriction endonuclease fragments high            203-205, 431-435. Cold Spring Harbor Laboratory, Cold Spring
    specific activity. Anal. Biochem. 132:6-13.                              Harbor, N.Y.
10. Ferone, R., M. H. Hanlon, S. C. Singer, D. F. Hunt. 1986.        22. Monk, M., J. Kinross. 1972. Conditional lethality recA
    Carboxyl linked glutamates folylpolyglutamates               recB derivatives strain Escherichia coli K-12     Escherichia coli. J. Biol. Chem. 261:16356-16362.                        temperature-sensitive deoxyribonucleic acid polymerase  J.
11. Ferone, R., S. C. Singer, M. H. Hanlon, S. Roland. 1983.             Bacteriol. 109:971-978.
    Isolation characterization E. coli mutant affected      23. Nonet, M. L., C. C. Marvel, D. Tolan. 1987. hisT-purF
    dihydrofolate- folylpolyglutamate-synthetase, p. 585-589.            region Escherichia coli K12 chromosome. J. Biol. Chem.
    J.  Blair (ed.), Chemistry biology pteridi